Literature DB >> 26114739

A Mixed-Methods Study of Pain-related Quality of Life in Sickle Cell Vaso-Occlusive Crises.

Richard J Lin1, Arthur T Evans, Kerri Wakeman, Michelle Unterbrink.   

Abstract

The quality of care for sickle cell disease patients hospitalized with a vaso-occlusive crisis (VOC) is poor, resulting in staggeringly high healthcare resource utilization. To evaluate in-patient care for VOC, we conducted a mixed-methods study of all adult sickle cell disease patients admitted with a VOC from 2010-2012. We quantitatively assessed the quality of care for all patients, and qualitatively studied a subset of frequently admitted patients. In total, there were 182 admissions from 57 unique patients. The median length of stay was 6 days and the 30-day readmission rate was 34.0%. We identified red blood cell transfusion and patient controlled analgesia use as predictors of increased length of stay. Interestingly, unlike prior findings, younger patients (18-30 years old) did not have increased healthcare resource utilization. Moreover, older age appeared to increase readmission rate and enhance the effect of patient controlled analgesia use on length of stay. Interviews of high healthcare resource utilizers revealed significant deficiencies in pain management and a strong desire for individualized care. This is the first study to examine in-patient predictors of acute healthcare resource utilization in sickle cell disease patients and to correlate them with qualitative perspectives of high healthcare resource utilizers.

Entities:  

Keywords:  Healthcare resource utilization; pain; quality of care; sickle cell disease; vaso-occlusive crisis (VOC)

Mesh:

Year:  2015        PMID: 26114739      PMCID: PMC7138462          DOI: 10.3109/03630269.2015.1055576

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  27 in total

1.  Transition from pediatric to adult care for patients with sickle cell disease.

Authors:  Susan E Hunt; Niraj Sharma
Journal:  JAMA       Date:  2010-07-28       Impact factor: 56.272

2.  The number of people with sickle-cell disease in the United States: national and state estimates.

Authors:  David C Brousseau; Julie A Panepinto; Mark Nimmer; Raymond G Hoffmann
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

Review 3.  Sickle cell disease pain management and the medical home.

Authors:  Jean L Raphael; Suzette O Oyeku
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

4.  Inpatient management of sickle cell pain: a 'snapshot' of current practice.

Authors:  Scott T Miller; Hae-Young Kim; Debra Weiner; Carrie G Wager; Dianne Gallagher; Lori Styles; Carlton D Dampier
Journal:  Am J Hematol       Date:  2012-01-09       Impact factor: 10.047

5.  Medical care utilization and mortality in sickle cell disease: a population-based study.

Authors:  Sadhna M Shankar; Patrick G Arbogast; Ed Mitchel; William O Cooper; Winfred C Wang; Marie R Griffin
Journal:  Am J Hematol       Date:  2005-12       Impact factor: 10.047

6.  Risk factors for hospital readmission within 30 days: a new quality measure for children with sickle cell disease.

Authors:  Melissa J Frei-Jones; Joshua J Field; Michael R DeBaun
Journal:  Pediatr Blood Cancer       Date:  2009-04       Impact factor: 3.167

7.  Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.

Authors:  Eduard J van Beers; Charlotte F J van Tuijn; Pythia T Nieuwkerk; Philip W Friederich; Jan H Vranken; Bart J Biemond
Journal:  Am J Hematol       Date:  2007-11       Impact factor: 10.047

8.  Daily assessment of pain in adults with sickle cell disease.

Authors:  Wally R Smith; Lynne T Penberthy; Viktor E Bovbjerg; Donna K McClish; John D Roberts; Bassam Dahman; Imoigele P Aisiku; James L Levenson; Susan D Roseff
Journal:  Ann Intern Med       Date:  2008-01-15       Impact factor: 25.391

Review 9.  Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

Authors:  Barbara P Yawn; George R Buchanan; Araba N Afenyi-Annan; Samir K Ballas; Kathryn L Hassell; Andra H James; Lanetta Jordan; Sophie M Lanzkron; Richard Lottenberg; William J Savage; Paula J Tanabe; Russell E Ware; M Hassan Murad; Jonathan C Goldsmith; Eduardo Ortiz; Robinson Fulwood; Ann Horton; Joylene John-Sowah
Journal:  JAMA       Date:  2014-09-10       Impact factor: 56.272

10.  The course and correlates of high hospital utilization in sickle cell disease: Evidence from a large, urban Medicaid managed care organization.

Authors:  C Patrick Carroll; Carlton Haywood; Peter Fagan; Sophie Lanzkron
Journal:  Am J Hematol       Date:  2009-10       Impact factor: 10.047

View more
  2 in total

1.  Impact of early analgesia on hospitalization outcomes for sickle cell pain crisis.

Authors:  Jason Payne; Inmaculada Aban; Lee M Hilliard; Jennifer Madison; Christina Bemrich-Stolz; Thomas H Howard; Amanda Brandow; Emily Waite; Jeffrey D Lebensburger
Journal:  Pediatr Blood Cancer       Date:  2018-08-27       Impact factor: 3.167

2.  Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local inhibition of anandamide hydrolysis.

Authors:  Megan L Uhelski; Kalpna Gupta; Donald A Simone
Journal:  Pain       Date:  2017-09       Impact factor: 7.926

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.